Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter Kraft, Ph.D.

Co-Author

This page shows the publications co-authored by Peter Kraft and Walter Willett.
Connection Strength

2.991
  1. Additive and Multiplicative Interactions Between Genetic Risk Score and Family History and Lifestyle in Relation to Risk of Type 2 Diabetes. Am J Epidemiol. 2020 05 05; 189(5):445-460.
    View in: PubMed
    Score: 0.226
  2. Metabolome-Wide Association Study of the Relationship Between Habitual Physical Activity and Plasma Metabolite Levels. Am J Epidemiol. 2019 11 01; 188(11):1932-1943.
    View in: PubMed
    Score: 0.218
  3. Joint effects of fatty acid desaturase 1 polymorphisms and dietary polyunsaturated fatty acid intake on circulating fatty acid proportions. Am J Clin Nutr. 2018 05 01; 107(5):826-833.
    View in: PubMed
    Score: 0.197
  4. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet. 2013 Apr; 45(4):392-8, 398e1-2.
    View in: PubMed
    Score: 0.138
  5. Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):927-36.
    View in: PubMed
    Score: 0.138
  6. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 Dec 15; 176(12):1121-9.
    View in: PubMed
    Score: 0.135
  7. ß-Carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr. 2012 Dec; 96(6):1379-89.
    View in: PubMed
    Score: 0.134
  8. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):437-44.
    View in: PubMed
    Score: 0.127
  9. Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):212-6.
    View in: PubMed
    Score: 0.125
  10. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2877-87.
    View in: PubMed
    Score: 0.116
  11. A lipid-related metabolomic pattern of diet quality. Am J Clin Nutr. 2020 12 10; 112(6):1613-1630.
    View in: PubMed
    Score: 0.059
  12. Associations of dairy intake with risk of mortality in women and men: three prospective cohort studies. BMJ. 2019 11 27; 367:l6204.
    View in: PubMed
    Score: 0.055
  13. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019 01 03; 104(1):21-34.
    View in: PubMed
    Score: 0.051
  14. Diet quality and genetic association with body mass index: results from 3 observational studies. Am J Clin Nutr. 2018 12 01; 108(6):1291-1300.
    View in: PubMed
    Score: 0.051
  15. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS Med. 2018 09; 15(9):e1002644.
    View in: PubMed
    Score: 0.050
  16. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat Genet. 2018 07; 50(7):968-978.
    View in: PubMed
    Score: 0.050
  17. Body mass index and breast cancer survival: a Mendelian randomization analysis. Int J Epidemiol. 2017 12 01; 46(6):1814-1822.
    View in: PubMed
    Score: 0.048
  18. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet. 2017 Dec; 49(12):1767-1778.
    View in: PubMed
    Score: 0.047
  19. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017 11 02; 551(7678):92-94.
    View in: PubMed
    Score: 0.047
  20. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol. 2017 03 15; 185(6):452-464.
    View in: PubMed
    Score: 0.045
  21. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. JAMA Oncol. 2016 Oct 01; 2(10):1295-1302.
    View in: PubMed
    Score: 0.044
  22. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol. 2016 06; 45(3):896-908.
    View in: PubMed
    Score: 0.043
  23. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res. 2016 09 01; 76(17):5103-14.
    View in: PubMed
    Score: 0.043
  24. Association of breast cancer risk loci with breast cancer survival. Int J Cancer. 2015 Dec 15; 137(12):2837-45.
    View in: PubMed
    Score: 0.041
  25. Genetic risk variants associated with in situ breast cancer. Breast Cancer Res. 2015 Jun 13; 17:82.
    View in: PubMed
    Score: 0.040
  26. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies. Breast Cancer Res Treat. 2015 Jun; 151(2):415-25.
    View in: PubMed
    Score: 0.040
  27. Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Res. 2015 Apr 22; 17:58.
    View in: PubMed
    Score: 0.040
  28. Identification of novel genetic markers of breast cancer survival. J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.040
  29. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):627-30.
    View in: PubMed
    Score: 0.039
  30. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2014 Nov 15; 180(10):1018-27.
    View in: PubMed
    Score: 0.038
  31. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol. 2014 Oct 01; 32(28):3111-7.
    View in: PubMed
    Score: 0.038
  32. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J Natl Cancer Inst. 2014 Jun; 106(6):dju085.
    View in: PubMed
    Score: 0.037
  33. A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer. PLoS One. 2014; 9(2):e85955.
    View in: PubMed
    Score: 0.037
  34. Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II. Cancer Epidemiol Biomarkers Prev. 2014 Mar; 23(3):516-24.
    View in: PubMed
    Score: 0.037
  35. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Int J Cancer. 2013 Jul 15; 133(2):495-504.
    View in: PubMed
    Score: 0.034
  36. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):688-96.
    View in: PubMed
    Score: 0.034
  37. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):82-91.
    View in: PubMed
    Score: 0.031
  38. Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res. 2011 May 01; 71(9):3287-95.
    View in: PubMed
    Score: 0.030
  39. Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab. 2011 Feb; 96(2):E360-7.
    View in: PubMed
    Score: 0.030
  40. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101.
    View in: PubMed
    Score: 0.028
  41. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009 May; 41(5):579-84.
    View in: PubMed
    Score: 0.026
  42. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):297-305.
    View in: PubMed
    Score: 0.026
  43. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008 Mar; 40(3):310-5.
    View in: PubMed
    Score: 0.024
  44. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007 Jul; 39(7):870-4.
    View in: PubMed
    Score: 0.023
  45. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007 May; 39(5):645-9.
    View in: PubMed
    Score: 0.023
  46. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007 Apr 01; 67(7):2951-6.
    View in: PubMed
    Score: 0.023
  47. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2408-17.
    View in: PubMed
    Score: 0.022
  48. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005 12; 5(12):977-85.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.